Media Room

For Immediate Release

Truven Health Analytics Defines Best Practices for Unlocking the Analytical Value of ICD-10 Disease Classification

Whitepaper projects expected improvements and recommends transition plan

Ann Arbor, MI, Aug. 21, 2012 — Truven Health Analytics, formerly the Healthcare business of Thomson Reuters, announced the publication of a new whitepaper that defines best practices for helping healthcare entities effectively transition to the new International Classification of Diseases, 10th Edition, Clinical Modification/Procedure Coding System (ICD-10).  The new classification system was introduced to enhance the specificity of the codes used to identify diagnoses.

Though the implementation date for ICD-10 was postponed by the Department of Health and Human Services, it has proposed October 1, 2014 as the new compliance date, and the new standard is expected to be mandated for all healthcare providers.  In the new report How to Prepare for the Analytic Value of ICD-10, Truven Health Analytics projects the improvements it expects to stem from the new system and outlines best practices for healthcare professionals to get the most out of the new standard.

Following are some of the key observations from the report:

  • ICD-10 Will Improve Quality: Truven Health Analytics believes that replacing ICD-9 with ICD-10 will provide more precise and comprehensive data for measuring healthcare service quality, safety and efficiency.
  • Proactive Health Management Panels: It will be essential for healthcare professionals to convene a series of panels to identify opportunities for using ICD-10 diagnosis information to better target specific interventions, highlighting specific clinical data that would prioritize patients or even indicate a specific intervention.
  • Retrospective Evaluation Panels: In addition to proactive analytics, experts in performance measurement should comprehensively review new ICD-10 “combination, ” “complication, ” and “etiology” codes, to anticipate the opportunity for enhanced performance measurement specifying complications and severity.
“Although there is reason to hope that the enhanced clinical specificity available with the transition to ICD-10 will provide new value to analytic methods, it is imperative that healthcare professionals start preparing now to extract the full value from the new coding system, ” said Bob Kelley, the paper’s lead author and senior vice president, Truven Health Analytics. “We remain committed to helping our clients continue to improve healthcare quality and cost by leveraging robust data and analytics in our products and solutions, and we feel that ICD-10 will help that process.”

To download the paper, please click here.

About Truven Health Analytics, part of the IBM Watson Health Business

Truven Health Analytics®, part of the IBM Watson Health™ business, provides market-leading performance improvement solutions built on data integrity, advanced analytics and domain expertise. For more than 40 years, our insights and solutions have been providing hospitals and clinicians, employers and health plans, state and federal government agencies, life sciences companies and policymakers, the facts they need to make confident decisions that directly affect the health and well-being of people and organizations in the US and around the world. The company was acquired by IBM in 2016 to help form a new business, Watson Health. Watson Health aspires to improve lives and give hope by delivering innovation to address the world’s most pressing health challenges through data and cognitive insights.

Truven Health Analytics owns some of the most trusted brands in healthcare, such as MarketScan®, 100 Top Hospitals®, Advantage Suite®, Micromedex®, Simpler® and ActionOI®. Truven Health has its principal offices in Ann Arbor, MI, Chicago, IL, and Denver, CO.


Brian Erni
For Truven Health Analytics
J. Roderick, Inc. Public Relations